29.11.2017 - The US Food and Drug Administration (FDA) has approved a new two-drug regimen for HIV that reports suggest could shake up the $22 billion market for products to treat the immune...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)